Total Payments
$11,340
2024 Payments
$1,092
Companies
64
Transactions
706
Medicare Patients
9,334
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$11,196 (98.7%)
Education$144.07 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,196 | 697 | 98.7% |
| Education | $144.07 | 9 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,143 | 76 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $974.44 | 63 | $0 (2024) |
| Novo Nordisk Inc | $855.71 | 49 | $0 (2023) |
| Lilly USA, LLC | $735.73 | 47 | $0 (2024) |
| ABBVIE INC. | $634.01 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $609.26 | 37 | $0 (2024) |
| Amarin Pharma Inc. | $522.58 | 39 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $518.14 | 35 | $0 (2023) |
| GlaxoSmithKline, LLC. | $484.47 | 30 | $0 (2024) |
| PFIZER INC. | $481.90 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,092 | 55 | AstraZeneca Pharmaceuticals LP ($211.57) |
| 2023 | $1,356 | 68 | Lilly USA, LLC ($181.03) |
| 2022 | $1,691 | 92 | ABBVIE INC. ($296.01) |
| 2021 | $1,370 | 95 | Amgen Inc. ($258.43) |
| 2020 | $1,246 | 82 | Novo Nordisk Inc ($210.12) |
| 2019 | $994.49 | 67 | Amarin Pharma Inc. ($189.04) |
| 2018 | $2,026 | 140 | Novo Nordisk Inc ($216.15) |
| 2017 | $1,565 | 107 | PFIZER INC. ($183.43) |
All Payment Transactions
706 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: VACCINES | ||||||
| 10/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Bone Health | ||||||
| 09/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/09/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE E3 SENSOR KIT - RETAIL (Device) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: VACCINES | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Neuromodulation | ||||||
| 07/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,964 | 5,589 | $938,085 | $375,762 |
| 2022 | 19 | 2,217 | 6,572 | $1.1M | $426,805 |
| 2021 | 24 | 2,457 | 7,543 | $983,165 | $425,752 |
| 2020 | 26 | 2,696 | 7,013 | $952,585 | $370,156 |
Total Patients
9,334
Total Services
26,717
Medicare Billing
$1.6M
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 217 | 1,413 | $210,537 | $87,093 | 41.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 218 | 1,682 | $214,878 | $81,772 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 322 | 680 | $184,052 | $61,267 | 33.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 230 | 342 | $97,812 | $33,988 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 264 | 264 | $94,225 | $33,510 | 35.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 216 | 326 | $49,878 | $28,973 | 58.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 119 | 356 | $29,548 | $20,551 | 69.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 50 | 129 | $14,964 | $10,778 | 72.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 76 | 76 | $10,702 | $5,456 | 51.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $10,879 | $3,921 | 36.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 76 | 76 | $2,743 | $2,456 | 89.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 35 | 48 | $5,731 | $1,836 | 32.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 15 | 15 | $4,245 | $1,580 | 37.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 26 | 28 | $2,232 | $1,036 | 46.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 17 | $3,255 | $982.29 | 30.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 51 | $1,672 | $465.75 | 27.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 21 | 22 | $201.36 | $75.02 | 37.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 29 | $532.00 | $21.85 | 4.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 301 | 2,077 | $252,500 | $101,921 | 40.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 221 | 1,694 | $252,406 | $94,771 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 323 | 665 | $194,180 | $58,180 | 30.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 184 | 267 | $111,873 | $40,971 | 36.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 251 | 251 | $94,125 | $32,744 | 34.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 110 | 388 | $32,204 | $20,728 | 64.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 71 | 262 | $30,392 | $18,817 | 61.9% |
About Dr. Gerald Simon, MD
Dr. Gerald Simon, MD is a Geriatric Medicine healthcare provider based in Countryside, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861450330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Simon, MD has received a total of $11,340 in payments from pharmaceutical and medical device companies, with $1,092 received in 2024. These payments were reported across 706 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($11,196).
As a Medicare-enrolled provider, Simon has provided services to 9,334 Medicare beneficiaries, totaling 26,717 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Other Specialties Internal Medicine
- Location Countryside, IL
- Active Since 05/03/2006
- Last Updated 02/01/2023
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1861450330
Products in Payments
- ENTRESTO (Drug) $867.18
- Ozempic (Drug) $548.67
- Vascepa (Drug) $522.58
- FARXIGA (Drug) $394.89
- ELIQUIS (Drug) $394.18
- EVENITY (Biological) $394.06
- XARELTO (Drug) $345.14
- Otezla (Drug) $322.55
- MOUNJARO (Drug) $286.59
- Prolia (Biological) $283.38
- TRELEGY ELLIPTA (Drug) $277.40
- LINZESS (Drug) $244.61
- TRULICITY (Drug) $242.07
- VRAYLAR (Drug) $238.60
- TOUJEO (Drug) $212.91
- Dexcom G6 Transmitter (Medical Supply) $208.93
- REXULTI (Drug) $200.67
- Victoza (Drug) $180.56
- NUEDEXTA (Drug) $178.59
- ZENPEP (Drug) $178.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.